Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 1, 2012, Pages 96-105

  Bhutada, Pravinkumar ^a   Mundhada, Yogita ^b   Humane, Vishwas ^c   Rahigude, Anand ^a   Deshmukh, Prashant ^a   Latad, Sandeep ^c   Jain, Kishor ^a  

^a SINHGAD COLLEGE OF PHARMACY   (India)

^b RTM NAGPUR UNIVERSITY   (India)

^c Agnihotri College of Pharmacy Wardha   (India)

Author keywords

Choline esterase; Dementia; Diabetes; Morris water maze; Object recognition

Indexed keywords

AGMATINE; CHOLINESTERASE; GLUCOSE; GLUTATHIONE; MALONALDEHYDE; STREPTOZOCIN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN CORTEX; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; HYPERGLYCEMIA; LEARNING; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY; MEMORY DISORDER; NONHUMAN; OPEN FIELD TEST; OXIDATIVE STRESS; PATTERN RECOGNITION; RAT; STREPTOZOCIN DIABETES;

AGMATINE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLINE RECEPTORS; LIGANDS; MALE; MEMORY DISORDERS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 84857783771     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.01.009     Document Type: Article

References (72)

1. Aigner T.G. Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 1995, 5:155-160.
2. Appleyard M.E. Non-cholinergic functions of acetylcholinesterase. Biochem Soc Trans 1994, 22:749-755.
3. Arteni N.S., Lavinsky D., Rodrigues A.L., Frison V.B., Netto C.A. Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem 2002, 78:465-469.
4. Arvanitakis Z., Wilson R.S., Bienias J.L., Evans D.A., Bennett D.A. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004, 61:661-666.
5. Battaglia V., Grancara S., Satriano J., Saccoccio S., Agostinelli E., Toninello A. Agmatine prevents the Ca(2+)-dependent induction of permeability transition in rat brain mitochondria. Amino Acids 2010, 38:431-437.
6. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol Rev 1998, 78:547-581.
7. Bhutada P., Mundhada Y., Bansod K., Bhutada C., Tawari S., Dixit P., et al. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats. Neurobiol Learn Mem 2010, 94:293-302.
8. Bhutada P., Mundhada Y., Bansod K., Tawari S., Patil S., Dixit P., et al. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behave Brain Res 2011, 220:30-41.
9. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996, 45:1259-1266.
10. Biessels G.J., Heide L.P., Kamal A. Ageing and diabetes: implications for brain function. Eur J Pharmacol 2002, 441:1-14.
11. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006, 5:64-74.
12. Biessels G.J., Kerssen A., de Haan E.H., Kappelle L.J. Cognitive dysfunction and diabetes: implications for primary care. Prim Care Diabetes 2007, 1:187-193.
13. Bolding K., Rudy J.W. Place learning in Morris water task: making the memory stick. Learn Mem 2006, 13:278-286.
14. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 2002, 5:561-568.
15. Cameron N.E., Eaton S.E.M., Cotter M.A., Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001, 44:1450-1458.
16. Chang C.H., Wu H.T., Cheng K.C., Lin H.J., Cheng J.T. Increase of beta-endorphin secretion by agmatine is induced by activation of imidazoline I(2A) receptors in adrenal gland of rats. Neurosci Lett 2010, 468:297-299.
17. Condello S., Curr M., Ferlazzo N., Caccamo D., Satriano J., Ientile R. Agmatine effects on mitochondrial membrane potential and NF-κB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells. J Neurochem 2010, 116:67-75.
18. Cui H., Lee J.H., Kim J.Y., Koo B.N., Lee J.E. The neuroprotective effect of agmatine after focal cerebral ischemia in diabetic rats. J Neurosurg Anesthesiol 2012, 24:39-50.
19. Cukierman T., Gerstein H.C., Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. J Diabetes 2005, 48:12-19.
20. de la Tremblaye P.B., Plamondon H. Impaired conditioned emotional response and object recognition are concomitant to neuronal damage in the amygdala and perirhinal cortex in middle-aged ischemic rats. Behave Brain Res 2011, 219:227-233.
21. Demady D.R., Jianmongkol S., Vuletich J.L., Bender A.T., Osawa Y. Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme. Mol Pharmacol 2001, 59:24-29.
22. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-77.
23. Ellman G.L., Courtney K.D., Abdres V., Feather-stone R.M. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 88-95.
24. Fukui K., Onodera K., Shinkai T., Suzuki S., Urano S. Impairment of learning and memory in rats caused by oxidative stress and aging, and changes in antioxidative defense systems. Ann NY Acad Sci 2001, 928:168-175.
25. Gallagher M., Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 1995, 5:161-168.
26. Gispen W.H., Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000, 23:542-549.
27. Halaris A., Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007, 21:885-900.
28. Hasanein P., Shahidi S. Effects of combined treatment with vitamins C and E on passive avoidance learning and memory in diabetic rats. Neurobiol Learn Mem 2010, 93:472-480.
29. Hoyer S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 1998, 105:412-422.
30. Hwang S.L., Liu I.M., Tzeng T.F., Cheng J.T. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats. Diabetologia 2005, 48:767-775.
31. Kamal A., Biessels G.J., Duis S.E., Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 2000, 43:500-506.
32. Kim H.B., Jang M.H., Shin M., Lim B.V., Kim Y.P., Kim K.J. Treadmill exercise increase cell proliferation in dentate gyrus of rats with streptozotocin-induced diabetes. J Diabetes Complicat 2003, 17:23-29.
33. Knopman D.S., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001, 56:42-48.
34. Kuhad A., Sethi R., Chopra K. Lycopene attenuates diabetes-associated cognitive decline in rats. Life Sci 2008, 83:128-134.
35. Kumagai A.K. Glucose transport in brain and retina: implications in the management and complications of diabetes. Diabetes Metab Res Rev 1999, 15:261-273.
36. Lee J.P., Chen W., Wu H.T., Lin K.C., Cheng J.T. Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats. Horm Metab Res 2011, 43:26-30.
37. Liu P., Bergin D.H. Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat. Neuroscience 2009, 159:951-961.
38. Liu P., Collie N.D. Behavioral effects of agmatine in naive rats are task- and delay-dependent. Neuroscience 2009, 163:82-96.
39. Liu I., Chen W., Cheng J. Mediation of β-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats. JPET 2003, 307:1196-1204.
40. Lu W., Dong H., Gong Z., Su R., Li J. Agmatine inhibits morphine-induced memory impairment in the mouse step-down inhibitory avoidance task. Pharmacol Biochem Behave 2010, 97:256-261.
41. Mankovsky B.N., Metzger B.E., Molitch M.E., Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J Diabetes Complicat 1996, 10:228-242.
42. Manschot S.M., Biessels J.G., Cameron N.E., Cotter M.A., Kamal A., Kappelle L.J., et al. Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats. Brain Res 2003, 966:274-282.
43. Mastrocola R., Restivo F., Vercellinatto I., Danni O., Brignardello E., Aragno M., et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005, 187:37-44.
44. McCall A.L. Cerebral glucose metabolism in diabetes mellitus. Eur J Pharmacol 2004, 490:147-158.
45. McKay B.E., Ladol W.E., Martin L.J., Galic M.A., Fournier N.M. Learning and memory in agmatine-treated rats. Pharmacol Biochem Behave 2002, 72:551-557.
46. Messier C. Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 2005, 26S:S26-S30.
47. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
48. Northam E.A., Rankins D., Lin A., Wellard R.M., Pell G.S., Finch S.J. Central nervous system functions in youth with type 1 diabetes 12years after disease onset. Diabetes Care 2009, 32:445-450.
49. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
50. Ozyazgan S., Bicakci B., Ozaydin A., Denizbasi A., Unluer E.E., Akkan A.G. The effect of agmatine on the vascular reactivity in streptozotocin-diabetic rats. Pharmacol Res 2003, 48:133-138.
51. Pascalis O., Hunkin N.M., Bachevalier J., Mayes A.R. Change in background context disrupts performance on visual paired comparison following hippocampal damage. Neuropsychologia 2009, 47:2107-2113.
52. Piazza F.V., Pinto G.V., Trott G., Marcuzzo S., Gomez R., Fernandes M.C. Enriched environment prevents memory deficits in type 1 diabetic rats. Behave Brain Res 2011, 217:16-20.
53. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain. TiPS 2000, 9:187-193.
54. Repetto E.M., Sanchez R., Cipelli J., Astort F., Calejman C.M., Piroli G.G., et al. Dysregulation of corticosterone secretion in streptozotocin-diabetic rats: modulatory role of the adrenocortical nitrergic system. Endocrinology 2010, 151:203-210.
55. Revsin Y., Rekers N.V., Louwe M.C., Saravia F.E., De Nicola A.F., de Kloet E.R., et al. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 2009, 34:747-758.
56. Reynolds R.M., Strachan M.W., Labad J., Lee A.J., Frier B.M., Fowkes F.G., et al. Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2010, 33:714-720.
57. Roosen P., Nawroth P.P., King G., Möller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetes Association, and the German Diabetes Society. Diab Metab Res Rev 2001, 17:189-212.
58. Rovet J.F. Diabetes. Pediatric neuropsychology: research, theory, and practice 2000, 336-365. Guilford Press, New York. K.W. Yeates, M.D. Ris, H.G. Taylor (Eds.).
59. Ryan C.M., Freed M.I., Rood J.A., Cobitz A.R., Waterhouse B.R., Strachan M.W. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006, 29:345-351.
60. Sanchez-Chavez G., Salceda R. Effect of streptozotocin-induced diabetes on activities of cholinesterases in the rat retina. IUBMB Life 2000, 49:283-287.
61. Schmatz R., Mazzanti C.M., Spanevello R., Stefanello N., Gutierres J., Correa M., et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009, 610:42-48.
62. Sima A.A.F., Kamiya H., Lia Z.G. Insulin C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004, 490:187-197.
63. Stranahan A.M., Lee K., Pistell P.J., Nelson C.M., Readal N., Miller M.G., Spangler E.L., Ingram D.K., Mattson M.P. Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels. Neurobiol Learn Mem 2008, 90:479-483.
64. Su C.H., Liu I.M., Chung H.H., Cheng J.T. Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Neurosci Lett 2009, 457:125-128.
65. Tiwari V., Kuhad A., Bishnoi M., Chopra K. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav 2009, 93:183-189.
66. Tuzcu M., Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 2006, 537:106-110.
67. Vitek M.P., Bjattacharya K., Glendening M.J., Stopa E., Vlassara H., Bucala R., et al. Advanced glycation end products contribute to amyloidosis in Alzheimer's disease. Proc Natl Acad Sci U S A 1994, 91:4766-4770.
68. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997, 46:S19-S37.
69. Zarifkar A., Choopani S., Ghasemi R., Naghdi N., Maghsoudi A.H., Maghsoudi N., et al. Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis. Eur J Pharmacol 2010, 634:84-88.
70. Zhang T., Sun X., Sun F. Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain. Neurochem Int 2010, 56:955-961.
71. Zhu M.Y., Wang W.P., Bissette G. Neuroprotective effects of agmatine against cell damage caused by glucocorticoids in cultured rat hippocampal neurons. Neuroscience 2006, 141:2019-2027.
72. Zhu M.Y., Wang W.P., Huang J., Regunathan S. Chronic treatment with glucocorticoids alters rat hippocampal and prefrontal cortical morphology in parallel with endogenous agmatine and arginine decarboxylase levels. J Neurochem 2007, 103:1811-1820.